Chiba, Japan

Takemori Toshifumi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Maruzen Petrochemical Company, Limited, Scivax Corporation.. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takemori Toshifumi. Retrieved from https://idiyas.com/inventor/takemori-toshifumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takemori Toshifumi: Pioneering Inventor from Chiba, Japan

Introduction: Takemori Toshifumi is a renowned inventor hailing from Chiba, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Takemori Toshifumi's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With over two decades of experience in research and development, Takemori Toshifumi has led numerous projects that have resulted in cutting-edge inventions in the fields of robotics, biotechnology, and telecommunications.

Collaborations: Throughout his career, Takemori Toshifumi has collaborated with leading technology companies, research institutions, and universities both in Japan and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: Takemori Toshifumi's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…